metricas
covid
Buscar en
Revista Colombiana de Psiquiatría
Toda la web
Inicio Revista Colombiana de Psiquiatría Polimorfismos en el gen del transportador de serotonina (SLC6A4) y el trastorno ...
Información de la revista
Vol. 41. Núm. 1.
Páginas 86-100 (marzo 2012)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 41. Núm. 1.
Páginas 86-100 (marzo 2012)
Artículos originales
Acceso a texto completo
Polimorfismos en el gen del transportador de serotonina (SLC6A4) y el trastorno afectivo bipolar en dos centros regionales de salud mental del Eje Cafetero*
Polymorphism in the Serotonin Transporter Gene (SLC6A4) and Emotional Bipolar Disorder in Two Regional Mental Health Centers from the Eje Cafetero (Colombia)
Visitas
1745
Lucero Rengifo Ramos1,
Autor para correspondencia
cenbiotep@utp.edu.co

Correspondencia: Lucero Rengifo Ramos, Centro de Biología Molecular y Biotecnología, Universidad Tecnológica de Pereira, Vereda La Julita, Pereira, Risaralda, Colombia
, Duverney Gaviria Arias1, Liliana Salazar Salazar2, Juan Pablo Vélez3, Stella Lozano Pardo4
1 Magíster en Biología Molecular y Biotecnología, Centro de Biología Molecular y Biotecnología de la Universidad Tecnológica de Pereira, vereda La Julita, Pereira, Risaralda, Colombia
2 Psiquiatra, directora científica del Instituto Especializado en Salud Mental, Clínica El Prado, Armenia, Quindío, Colombia
3 Médico, subdirector científico del Hospital Mental de Risaralda (HOMERIS), Pereira, Risaralda, Colombia
4 Psicóloga, estudiante de Maestría en Biología Molecular y Biotecnología de la Universidad Tecnológica de Pereira, vereda La Julita, Pereira, Risaralda, Colombia
Este artículo ha recibido
Información del artículo
Resumen
Introducción

Los polimorfismos indel en la región promotora y los polimorfismos de tamaño en el intrón 2 del gen transportador de serotonina se han asociado con el trastorno afectivo bipolar 1 (TAB 1) en diferentes poblaciones. El objetivo fue analizar las frecuencias genotípicas y alélicas en ambas regiones del gen en un estudio de casos y controles en Risaralda y Quindío (Colombia) para encontrar una asociación con TAB 1 y compararlas con estudios similares.

Métodos

Se analizaron 133 pacientes y 120 controles. Con PCR se analizaron los polimorfismos indel L y S de la región promotora y los de tamaño (VNTR) STin 2.10 y STin 2.12 del segundo intrón del gen SLC6A4.

Resultados

Las frecuencias genotípicas y alélicas en los polimorfismos S y L fueron muy similares en casos y controles. Sin embargo, el genotipo LL se encontró incrementado no significativamente en la población general con TAB 1 (OR=1,89; IC95%= 1,1-3,68) y al separarla por género. Los OR para este genotipo en la población general (OR=1,89; IC95%=1,1-3,68) en mujeres (OR=2,22; IC95%=1,04-5,66) y en hombres (OR=1,62; IC95%=0,71-4,39). En los polimorfismos VNTR STin 2.10 y STin2.212 tampoco se observaron diferencias significativas entre las frecuencias genotípicas y alélicas.

Conclusiones

No encontramos asociación entre los polimorfismos de las regiones 5-HTTLPR y el intrón 2 del gen transportador de serotonina en los pacientes con TAB 1, ni en la población total, ni al separarla por género. Nuestros resultados son similares a los encontrados en poblaciones caucásicas y difieren de los encontrados en asiáticas y brasileras.

Palabras clave:
Transportador de serotonina
promotor
segundo intron
frecuencias genotipicas
frecuencias alélicas
Abstract
Introduction

The indel polymorphisms in the promoting region and the 2nd intron polymorphisms in the serotonin transporter gene (SLC6A4) have been associated to bipolar disorder 1 (BD1) in several population studies. The objective was to analyze the genotypic and allelic frequencies in both gene regions in a study of cases and controls with individuals from Risaralda and Quindío (Colombia) so as to establish possible associations to BD1, and compare results with previous and similar studies.

Methods

133 patients and 120 controls were studied. L and S indel polymorphisms in the promoting region were analyzed by PCR, together with VNTR STin2.10 and STin 2.12 VNTRs polymorphisms in the 2nd intron of the SL-C6A4 gene

Results

Genotypic and allelic frequencies for the S and L polymorphisms were similar both in cases and controls. However, the LL genotype was significantly increased both in BD1 population (OR=1.89; CI95%=1.1-3.68), and when discriminated by gender. This particular genotype in general population is OR=2.22; IC95%=1.04-5.66 for women, and OR=1.62; IC 95%=0.71-4.39 for men. No significant genotypic and allelic differences were found for VNTR STin2.10 and STin 2.12. polymorphisms.

Conclusions

No association was found between polymorphisms of 5-HTTLPR polymorphisms and the 2nd intron of the serotonin transporting gene in general patients with BD1, nor when compared by gender. Our results are similar to those reported for Caucasian populations and differ from those of Asian and Brazilian populations.

Key words:
Serotonin transporter
promoter
2nd intron
genotype frequency
allelic frequency
El Texto completo está disponible en PDF
Referencias
[1]
American Pychyatric Association (APA).
Diagnostic and statistical manual of mental disorders, 4th ed., APA, (2005),
[2]
JW Smoller, CT Finn.
Family, twin, and adoption studies of bipolar disorder.
Am J Med Genet C Semin Med Genet, 123C (2003), pp. 48-58
[3]
KR Merikangas, HS Akiskal, J Angst, et al.
Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication.
Arch Gen Psychiatry, 64 (2007), pp. 543-552
[4]
JF Goldberg, M Harrow.
Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up.
J Affect Disord, 81 (2004), pp. 123-131
[5]
República de Colombia, Ministerio de la Protección Social (MPS), FES.
Estudio Nacional de Salud Mental-Colombia 2003, MPS, FES, (2005),
[6]
RL Kohn.
Los trastornos mentales en América Latina y el Caribe: asunto prioritario para la salud pública.
Rev Panam Salud Pública/Pan Am J Public Health, 18 (2005), pp. 229-240
[7]
JH Barnett, JW Smoller.
The genetics of bipolar disorder (review).
Neuroscience, 164 (2009), pp. 331-343
[8]
NF Craddock.
Genetics of affective (mood) disorders.
Euro J Hum Genet, 14 (2006), pp. 660-668
[9]
MT Tsuang, L Taylor, SV Faraone.
An overview of the genetics of psychotic mood disorders.
J Psychiatr Res, 38 (2004), pp. 3-15
[10]
MB McQueen, B Devlin, SV Faraone, et al.
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q.
Am J Hum Genet, 77 (2005), pp. 582-595
[11]
S Ramamoorthy, AL Bauman, KR Moore, et al.
Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.
Proc Natl Acad Sci USA, 90 (1993), pp. 2542-2546
[12]
SJ Kim, N Cox, R Courchesne, et al.
Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder.
Mol Psychiatry, 7 (2002), pp. 278-288
[13]
A Heils, A Teufel, S Petri, et al.
Allelic variation of the human serotonin transporter gene expression.
J Neurochem, 66 (1996), pp. 2621-2624
[14]
DA Collier, G Stober, T Li, et al.
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders.
Mol Psychiatry, 1 (1996), pp. 453-460
[15]
B Gutiérrez, MJ Arranz, DA Collier, et al.
Serotonin transporter gene and risk for bipolar affective disorder: An association study in a Spanish.
Biol Psychiatry, 43 (1998), pp. 843-847
[16]
MR Hoehe, B Wendel, I Grunewald, et al.
Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders.
Am J Med Genet, 81 (1998), pp. 1-3
[17]
J Ospina-Duque, C Duque, L Carvajal-Carmona, et al.
An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia.
Neurosci Lett, 292 (2002), pp. 199-202
[18]
I Meira-Lima, L Michelon, Q Cordeiro, et al.
Allelic association analysis of the functional insertion/deletion polymorphism in the promoter region of the serotonin transporter gene in bipolar affective disorder.
J Mol Neurosci, 27 (2005), pp. 219-224
[19]
M Nakamura, S Ueno, A Sano, et al.
The human serotonin transporter gene inked polymorphism (5-HTTLPR) shows ten novel allelic variants.
Mol Psychiatry, 5 (2000), pp. 32-38
[20]
MH Bloch, A Landeros-Weisenberger, S Sen, et al.
Association of the SERT polymorphism and OCD: Systematic review.
Am J Med Genet B Neuropsych Genet, 147B (2008), pp. 850-858
[21]
KP Lesch, D Bengel, A Heils, et al.
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.
Science, 274 (1996), pp. 1527-1531
[22]
M Willeit, J Stastny, W Pirker, et al.
No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism.
Biol Psychiatry, 50 (2001), pp. 8-12
[23]
R Kaiser, B Muller-Oerlinghausen, D Filler, et al.
Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter.
Am J Med Genet, 114 (2002), pp. 323-328
[24]
RB Williams, DA Marchuk, KM Gadde, et al.
Serotonin-related gene polymorphisms and central nervous system serotonin function.
Neuropsychopharmacol, 28 (2003), pp. 533-541
[25]
SP David, NV Murthy, EA Rabiner, et al.
A functional genetic variation of the serotonin5-HT transporter polymorphism affects 5-HT1A receptor binding in humans.
J. Neurosci, 25 (2005), pp. 2586-2590
[26]
F Silva-Neves, L Malloy-Diniz, MA Romano-Silva, et al.
Is the serotonin transporter polymorphism (5-HTTLPR) a potential marker for suicidal behavior in bipolar disorder patients?.
J Affect Disorders, 125 (2010), pp. 98-102
[27]
M Nobile, B Begni, R Giorda, et al.
Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents.
J Am Acac Child Psy, 38 (1999), pp. 1396-1402
[28]
N Craddock, MJ Owen.
Modern molecular genetic approaches to psychiatric disease.
Br Med Bull, 52 (1996), pp. 434-452
[29]
F Bellivier, M Leroux, CH Henry, et al.
Serotonin transporter gene polymorphism influence age at onset in patients with bipolar affective disorder.
Neurosci Lett, 334 (2002), pp. 17-20
[30]
AG Cardno, FV Rijsdijk, PC Sham, et al.
A twin study of genetic relationships between psychotic symptoms.
Am J Psychiatry, 159 (2002), pp. 539-545
[31]
WH Berrettini.
Molecular linkage studies of bipolar disorders.
Bipolar Disorders, 3 (2001), pp. 276-283
[32]
AD Ogilvie, S Battersby, VJ Bubb, et al.
Polymorphism in serotonin transporter gene associated with susceptibility to major depression.
Lancet, 347 (1996), pp. 731-733
[33]
HJ Cho, I Meira-Lima, Q Cordeiro, et al.
Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis.
Mol Psychiatry, 10 (2005), pp. 771-781
[34]
JJ Mann, YY Huang, MD Underwood, et al.
A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.
Arch Gen Psychiatry, 57 (2000), pp. 729-738
[35]
F Bellivier, CH Henry, A Szöke, et al.
Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression.
Neurosci Lett, 255 (1998), pp. 143-146
[36]
A Heinz, DW Jones, CH Mazzanti, et al.
A Relationship between Serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.
Biol Psychiatry, 47 (2000), pp. 643-649
[37]
H Kunugi, M Hattori, T Kato, et al.
Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder.
Mol Psychiatry, 2 (1997), pp. 457-462
[38]
JB Fan, P Sklar.
Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia.
Mol Psychiatry, 10 (2005), pp. 928-938
[39]
K Ohara, Y Suzuki, M Ochiai, et al.
A Variable-number-tandem-repeat of the seroton transporter gene and anxiety disorder.
Prog Neuropsychopharmacol Biol Psychiatry, 23 (1999), pp. 5565

Conflictos de interés: Los autores manifiestan que no tienen conflictos de interés en este artículo.

Este proyecto fue financiado por la Red de Universidades Públicas del Eje Cafetero ‘Alma Mater’. Resultados parciales de esta investigación fueron presentados en el XLV Congreso Nacional de Ciencias Biológicas realizado en Armenia, Quindío, entre el 5 y el 8 de octubre. Ponente: Stella Lozano Pardo.

Copyright © 2012. Asociación Colombiana de Psiquiatría
Opciones de artículo